Industry Reports
CPhI Worldwide Report: CMOs will account for four of the five top bio manufacturing capacities in 2025
Ahead of the world’s largest pharma event – CPhI Worldwide taking place in Milan, Italy (9-11 November, 2021) – the third part of the CPhI Annual Report is released with key findings for biologics manufacturing, biotechs and CDMOs.
CPhI experts...
Industry Reports
Short term reshoring the catalyst for longer term manufacturing innovations by 2030
The second part of the 2021 CPhI Annual Report looks ahead to predict the pharma manufacturing, therapeutic and technology environment in 2030. The analysis foresees the use of automated cobots, AI, real-time release and rapid growth in new areas...
Industry Reports
Veeva Digital Clinical Trials Survey Report
Veeva released the largest survey on digital trials examining the opportunities and implications of decentralized approaches on clinical trials by gathering the experiences and opinions of more than 280 clinical leaders worldwide. In case you find it useful for...
Industry Reports
Pharmapack Report 2021: Digital data democratization, environmental factors & user experience driving device innovation in 2022
Pharmapack Report 2021 are released ahead of Pharmapack Europe, which will be held next week at Paris Expo, Porte de Versailles (October 13-14, 2021). The event is the leading hub for stakeholders across all parts of the pharmaceutical packaging...
Industry Reports
New Elsevier report highlights progress towards disease-modifying treatments for pancreatitis
Elsevier, a global leader in research publishing and information analytics, has published the findings from a new report on emerging trends for pancreatitis in the scientific literature. Acute pancreatitis is the most common GI-related cause for hospitalization in the...
Industry Reports
Oncology Is a Major Focus for Many AI Drug Discovery Companies, Reports IDTechEx
The application of artificial intelligence (AI) in the drug discovery process is promising to drastically cut down timelines and costs of bringing new therapies to patients. Typically, the development of a drug costs companies more than $1 billion, in...
Drug Research
Phesi Big Data Analysis of Over 200,000 Hepatitis B and C Patients Identifies Typical Patient to Help Drive Forward Disease Elimination Goals
Phesi Inc., a data-driven provider of AI-powered clinical development analytics products and solutions, has analyzed data from 209,860 hepatitis B (HBV) and C (HCV) patients, from 940 trial arms/cohorts to build a picture of the “typical” patient and identify...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read